Controlling Polymorphism with Membrane-Based Crystallizers: Application to Form I and II of Paracetamol
Source abstract
Abstract
The selective crystallization of either stable or metastable polymorph of paracetamol was obtained by membrane crystallization. The membrane acts as a selective medium for solvent evaporation and as active substrate for heterogeneous nucleation. This allows switching between a thermodynamically and a kinetically controlled nucleation stage.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallization and Solubility Studies · Analytical Chemistry and Chromatography · Drug Solubulity and Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute on Membrane Technology (ITM-CNR), c/o University of Calabria, Cubo 17/C, 87030 Rende, Italy, and Department of Chemical Engineering and Materials, University of Calabria, Cubo 41/A, 87030 Rende, Italy
References (26)
Show source-provided references
1. Ulrich J. · J. Cryst. Growth · 2002 · 237 · 213010.1016/S0022-0248(01)02284-9 ↗
2. Di Profio G. · Cryst. Growth Des. · 2007 · 7 · 52610.1021/cg0605990 ↗
3. Curcio E. · J. Cryst. Growth · 2003 · 247 · 16610.1016/S0022-0248(02)01794-3 ↗
4. Di Profio G. · J. Cryst. Growth · 2003 · 257 · 35910.1016/S0022-0248(03)01462-3 ↗
5. Di Profio G. · J. Struct. Biol. · 2005 · 150 · 4110.1016/j.jsb.2004.12.006 ↗
6. Di Profio G. · Ind. Eng. Chem. Res. · 2005 · 44 · 1000510.1021/ie0508233 ↗
7. Curcio E. · J. Phys. Chem. B · 2006 · 110 · 1243810.1021/jp061531y ↗
8. Haisa M. · Acta Crystallogr., Sect. B · 1976 · 32 · 128310.1107/S0567740876012223 ↗
9. Haisa M. · Acta Crystallogr., Sect. B · 1974 · 30 · 251010.1107/S0567740874007473 ↗
10. Bürger A. · Acta Pharm. Technol. · 1982 · 28 · 1
11. Di Martino P. · Int. J. Pharm. · 1996 · 128 · 110.1016/0378-5173(95)04127-3 ↗
12. Nichols G. · J. Pharm. Sci. · 1998 · 87 · 68410.1021/js970483d ↗
13. Beyer T. · J. Am. Chem. Soc. · 2001 · 123 · 508610.1021/ja0102787 ↗
14. Joiris E. · Pharm. Res. · 1998 · 15 · 112210.1023/A:1011954800246 ↗
15. Mikhailenko M. A. · J. Cryst. Growth · 2004 · 265 · 61610.1016/j.jcrysgro.2004.02.091 ↗
16. Ristic R. I. · J. Phys. Chem. B · 2001 · 105 · 905710.1021/jp003757l ↗
17. Boerrigter S. X. M. · Cryst. Growth Des. · 2002 · 2 · 35710.1021/cg020012r ↗
18. Al-Zoubi N. · J. Pharm. Biomed. Anal. · 2002 · 29 · 45910.1016/S0731-7085(02)00098-5 ↗
19. Moynihan H. A. · Int. J. Pharm. · 2002 · 247 · 17910.1016/S0378-5173(02)00420-9 ↗
20. Ivanova B. B. · J. Mol. Struct. · 2005 · 738 · 23310.1016/j.molstruc.2004.12.036 ↗
21. He G. · Cryst. Growth Des. · 2006 · 6 · 174610.1021/cg0602515 ↗
22. Kim K.-J. · Chem. Eng. Sci. · 2001 · 56 · 231510.1016/S0009-2509(00)00450-4 ↗
23. Ostwald W. · Z. Phys. Chem. · 1897 · 22 · 28910.1515/zpch-1897-2233 ↗
24. Sohnel O. · J. Colloid. Interface Sci. · 1988 · 123 · 4310.1016/0021-9797(88)90219-6 ↗
25. Lang M. · J. Am. Chem. Soc. · 2002 · 124 · 1483410.1021/ja0286526 ↗
26. Granberg R. A. · J. Chem. Eng. Data · 1999 · 44 · 139110.1021/je990124v ↗